Keywords: α-سینوکلین; Parkinson disease; Neuropathology; α-Synuclein; Lewy body;
مقالات ISI α-سینوکلین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: α-سینوکلین; αS; alpha-synuclein; PD; Parkinson's disease; ER/M; endoplasmic reticulum/microsomes; HMW; high molecular weight; SpC; spinal cord; Ctx; cortex; PreS; presymptomatic; Tg; transgenic; nTg; non-Tg; α-Synuclein; Microsomes; Endoplasmic reticulum; Oligomers
Keywords: α-سینوکلین; α-Syn; α-synuclein; AD; Alzheimer's disease; BP; Biological Process; CAMS; Chinese Academy of Medical Sciences; CAPS; calcium-dependent activator of secretion; CC; Cellular component; CCK; Cell counting kit; DA; dopamine; DAVID; Database for annotation,
Keywords: α-سینوکلین; Aβ; beta-amyloid; APOE; apolipoprotein E; APP; amyloid precursor protein; AD; Alzheimer's disease; CRISPR; clustered regularly interspaced short palindromic repeats; DAT; dopamine transporter; ER; estrogen receptor; FAD; familial Alzheimer's disease;
Keywords: α-سینوکلین; α-Synuclein; Triphenylmethane dyes; Aggregation; Fibrillisation; A11; Synucleinopathies; Parkinson's disease;
Keywords: α-سینوکلین; PC12 cells; Rat adrenal pheochromocytoma cells; SNCA; α-synuclein; pDNA; plasmid DNA; BBB; blood-brain barrier; GNP; gold nanoparticles; CTS; chitosan; DTPA; 3,3â²-dithiodipropionic acid; NHS; N-hydroxysuccinimide; DTSP; dithiobis-(succinimidyl propio
Keywords: α-سینوکلین; α-synuclein; Mitochondria; Parkinson's disease; Mitochondrial metabolism;
Keywords: α-سینوکلین; 3-Iodo-l-tyrosine; Parkinson; α-Synuclein; Tyrosine-hydroxylase; jejunum; Nigrostriatal;
Keywords: α-سینوکلین; Membrane; Amyloid; Helical; α-Synuclein; IAPP; Aggregation;
Keywords: α-سینوکلین; Amyloid β; Molecular dynamics simulations; Amylin; α-Synuclein; Tau; Aggregation;
Keywords: α-سینوکلین; α-Syn; α-synuclein; Aβ; beta-amyloid; AD; Alzheimer's disease; AON; anterior olfactory nucleus; ALS; amyotrophic lateral sclerosis; APP; amyloid precursor protein; CBD; corticobasal degeneration; CJD; Creutzfeldt-Jakob disease; DLB; dementia with Lewy
Keywords: α-سینوکلین; Multiple system atrophy; PRNP; Prion disease; Prion protein; Sporadic Creutzfeld-Jakob disease; α-synuclein; α-syn; confidence intervals; CI; cytoplasmic inclusions; GCIs; multiple system atrophy; MSA; sporadic Creutzfeld-Jakob disease; sCJD; odds ratio
Keywords: α-سینوکلین; Alzheimer's disease (AD); Cerebrovascular disease; Lewy body disease; Frontotemporal degeneration; β-amyloid; Tau; α-Synuclein; TDP-43;
Keywords: α-سینوکلین; AraC; cytosine arabinoside; αSyn; α-synuclein; BSA; bovine serum albumin; Con; control; CQ; chloroquine; DIV; days in vitro; DMSO; dimethyl sulfoxide; E. coli; Escherichia coli; FBS; fetal bovine serum; GAPDH; glyceraldehyde 3-phosphate dehydrogenase; G
A moderate metal-binding hydrazone meets the criteria for a bioinorganic approach towards Parkinson's disease: Therapeutic potential, blood-brain barrier crossing evaluation and preliminary toxicological studies
Keywords: α-سینوکلین; Parkinson's disease; α-Synuclein; Metal hypothesis; Copper; MPAC; Wistar rats;
Keywords: α-سینوکلین; AD; Alzheimer's disease; PD; Parkinson's disease; DLB; dementia with Lewy bodies; MSA; multiple system atrophy; ALS; amyotrophic lateral sclerosis; αSyn; α-synuclein; TDP-43; TAR DNA binding protein of 43 kDa; FTLD; frontotemporal lobar degeneration; P
Keywords: α-سینوکلین; Aβ; β-amyloid; AD; Alzheimer's disease; APD; atipical parkinsonian diseases; α-syn; α-synuclein; CBS; corticobasal syndrome; DLB; dementia with lewy bodies; DLN; dorsolateral tegmental nucleus; MCI; mild cognitive impairment; HD; Huntington's dise
Keywords: α-سینوکلین; Parkinson's disease; Rotenone; Apigenin; α-synuclein; Inflammatory cytokines;
Design, synthesis, immunocytochemistry evaluation, and molecular docking investigation of several 4-aminopyridine derivatives as potential neuroprotective agents for treating Parkinson's disease
Keywords: α-سینوکلین; Neuroprotective agents; Parkinson's disease; 4-Aminopyridine derivatives; α-Synuclein; Inflammation; Oxidative stress; Rho kinase;
Keywords: α-سینوکلین; Proteasome; α-Synuclein; Parkinson's disease; Mass spectrometry; High-throughput screening; Agonist;
Keywords: α-سینوکلین; Lewy body; α-synuclein; Dementia; Diagnosis; Management;
Keywords: α-سینوکلین; Solvatochromic probes; Fluorescence; Protein-membrane interaction; Affinity; Binding stoichiometry; α-synuclein;
Keywords: α-سینوکلین; α-synuclein; α-syn; APP; amyloid precursor protein; AD; Alzheimer's disease; ALS; amyotrophic lateral sclerosis; Aβ; β-amyloid; CSF; Cerebrospinal fluid; DLB; Dementia with Lewy Bodies; FTD; Fronto temporal dementia; IMR; immunomagnetic reduction; L
Keywords: α-سینوکلین; AD; Alzheimer's disease; PD; Parkinson's disease; ssNMR; solid-state NMR; α-syn; α-synuclein; β2m; β2-microglobulin; apoA-I; apolipoprotein A-I; polyQ; polyglutamine; IDP; intrinsically disordered protein; htt; huntingtin; MD; molecular dynamics; MHC
Keywords: α-سینوکلین; Parkinson's Disease; Neurodegeneration; Symptomatic; Disease modification; Dopamine; α-Synuclein;
Keywords: α-سینوکلین; Aβ; beta-amyloid peptide; AAV; adeno-associated virus; ABAD; amyloid-beta-binding alcohol dehydrogenase; AD; Alzheimer's disease; ALP; autophagy-lysosome pathways; Apaf-1; apoptic protease-activating factor 1; APP; amyloid precursor protein; AICD; APP in
Keywords: α-سینوکلین; α-syn; α-synuclein; AD; Alzheimer's Disease; Al; aluminum; C. elegans; Caenorhabditis elegans; CPF; chlorpyrifos; DA; dopamine; DDE; dichlorodiphenyldichloroethylene; DDT; dichlorodiphenyltrichloroethane; ETC; electron transport chain; FAO; fatty acid
Keywords: α-سینوکلین; α-GlcChol; 1-O-cholesteryl-α-d-glucopyranoside; α-Syn; α-synuclein; β-GlcChol; 1-Î-cholesteryl-β-d-glucopyranoside or β-cholesterylglucoside; BMP; bis (monoacylglycero) phosphate; CERT; ceramide transfer protein; CNS; central nervous system; ER; e
Keywords: α-سینوکلین; 6-OHDA; 6-hydroxydopamine; α-syn; α-synuclein; ACC; Anterior Cingulate Cortex; ADMA; asymmetric dimethylarginine; Alda-1; N-(1,3-Benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide; Aldh1/Aldh2; aldehyde dehydrogenases 1/2; ALDH2; mitochondrial aldehyde dehyd
Keywords: α-سینوکلین; α-synuclein; Dopamine; 5-hydroxytryptamine; Neuroinflammation; Positron emission tomography; Single photon emission computed tomography; Tau;
Keywords: α-سینوکلین; Neurodegenerative disease; Parkinson's disease; α-synuclein; Amyotrophic lateral sclerosis; TDP-43; Niemann-Pick disease;
Keywords: α-سینوکلین; Genetics; Lysosome; α-Synuclein; Gaucher's disease; GBA;
Keywords: α-سینوکلین; PD; Parkinson's disease; SNpc; Substantia Nigra pars compacta; αSyn; α-synuclein; VTA; ventral tegmental area; UPS; ubiquitin proteasome systems; HAT; histone acetyltransferase; HDAC; histone deacetylase; HDACI; histone deacetylase inhibitor; TH; tyro
Keywords: α-سینوکلین; Dinitrophenolic herbicides; In vitro neurotoxicology; Endoplasmic reticulum; Single cell Fura-2 Ca2+-imaging; Caspase-mediated apoptosis; α-Synuclein;
Keywords: α-سینوکلین; α-syn; α-synuclein; Aβ; β-amyloid; AD; Alzheimer's disease; ADAMs; a disintegrin and metalloproteinases; ALS; amyotrophic lateral sclerosis; BSE; bovine spongiform encephalopathy; CJD; Creutzfeldt-Jakob disease; CNS; central nervous system; CSF; cer
Keywords: α-سینوکلین; α-Synuclein; Oligodendroglia; Microglia; Astroglia; Parkinson's disease; Multiple system atrophy; Dementia with Lewy bodies; Glial cytoplasmic inclusions; Lewy bodies;
Keywords: α-سینوکلین; Prunus persica L.; Polyphenol; Antioxidant activity; β-amyloid; α-synuclein;
Keywords: α-سینوکلین; α-syn; alpha synuclein; Tf; transferrin; TfR; transferrin receptor; DA; dopamine; PD; Parkinson's disease; Tf-Fe; transferrin bound iron; NTBI; non transferrin bound iron; SN; substantia nigra; RPE; retinal pigment epithelium; OCT; optical coherence tomo
Keywords: α-سینوکلین; OS; oxidative stress; CNS; central nervous system; ROS; reactive oxygen species; SOD; superoxide dismutase; CAT; catalase; Cu; copper; Zn; zinc; Mn; manganese; Fe; iron; Ni; nickel; DA; dopamine; PHOX; NADPH oxidase; Nrf2; nuclear factor erythroid 2-relat
Keywords: α-سینوکلین; Hereditary diffuse leukoencephalopathy with axonal spheroids; Colony-stimulating factor 1 receptor; Neurodegeneration; Spheroids; White matter degeneration; α-Synuclein;
Keywords: α-سینوکلین; Parkinsonism; Gene; SNCA; α-synuclein; Mutation; Triplication;
Keywords: α-سینوکلین; Multiple system atrophy; Transcriptome; Gene regulation; α-Synuclein; Neurodegenerative diseases;
Keywords: α-سینوکلین; Autophagy; LC3; Lewy body disease; Trehalose; α-Synuclein; Chaperone;
Keywords: α-سینوکلین; Parkinson's disease; cell trafficking; Tau; α-synuclein;
Keywords: α-سینوکلین; α-synuclein; β-glucocerebrosidase; Gaucher disease; Parkinson disease;
Keywords: α-سینوکلین; Adeno-associated viral vectors; Animal model; α-Synuclein; Parkinson's disease; PET imaging;
Keywords: α-سینوکلین; Parkinson disease; α-Synuclein; Lewy bodies; Mitochondrial dysfunction;
Keywords: α-سینوکلین; Variable domain of heavy-chain antibody; Inhibition of protein misfolding and aggregation; Protein misfolding diseases; Amyloidoses; VHH; Nanobody; Ab; antibody; Aβ; amyloid β-peptide; AD; Alzheimer's disease; ANS; anilino naphthalene-sulfonic acid; AP;
Keywords: α-سینوکلین; Hcrt; hypocretin; LHT; lateral hypothalamus; LC; locus coeruleus; PD; Parkinson's disease; DLB; dementia with Lewy bodies; AD; Alzheimer's disease; RBD; REM sleep behavioral disorder; SOREM; sleep onset of REM sleep; EDS; excessive daytime sleepiness; SOO
Keywords: α-سینوکلین; α-synuclein; Methamphetamine; DNA methylation; Methyl CpG binding protein 2; DNA methyltransferase 1;